Faster FDA Review Process Bodes Well for NPS Pharmaceuticals and Cel-Sci Corp
NEW YORK, NY-- - It has been a banner year already for the biotechnology sector with new chemical and molecular entity approvals reaching a 20-year high. Additionally, FDA officials claim drug applications ...

FDA Touts Pace of Its Drug Approvals Over European Counterparts
U.S. regulators logged the second- highest approval rate for new drugs in a decade in fiscal 2011, clearing at least two dozen cancer medicines and other compounds before European counterparts.

Faster FDA Drug Reviews Should Benefit Cardium Therapeutics and CytRx Corporation
NEW YORK, NY-- - It has been a banner year already for the biotechnology sector with new chemical and molecular entity approvals reaching a 20-year high. Additionally, FDA officials claim drug applications ...